Selling pressure pushes UiPath stock lower in today's trading

Traders Union
All News
Financial News
Uipath slides 2.47% today on weak action

Highlights

UiPath posted Q1 FY27 revenue of $418 million, up 17% year-over-year, and achieved its first GAAP operating profit.
International growth was underlined by launching the Maestro orchestration platform with One NZ, indicating ongoing enterprise adoption of automation solutions.
Shares remain under sustained downside pressure, trading below key averages with technicals signaling a 73% likelihood of further losses toward support at $10, and an expected five-day range of $9.71 to $10.35.

Product gains and global rollout meet sustained selling momentum

UiPath reported Q1 FY27 revenue of approximately $418 million, representing a 17% year-over-year increase and its first-ever GAAP operating profit. International expansion was highlighted by the Maestro orchestration platform launch with telecommunications provider One NZ to advance AI-driven automation in enterprises. These developments reflect growing adoption of UiPath’s automation solutions and continued product innovation, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, points to ongoing downside pressure in UiPath despite fundamental progress. He notes that trading below all relevant moving averages underscores weak technical momentum. The first GAAP profit and robust international projects are positive, but sentiment remains suppressed due to heavy selling and weak indicator readings. Kharitonov highlights that oversold technicals alone may not be enough for reversal given a 73% probability of further declines. "Caution is warranted here, as technical and sentiment headwinds could outweigh improvement in fundamentals for now."

Viktoras Karapetjanc, expert at Traders Union, sees UiPath’s results as laying groundwork for future upside. He highlights strong year-over-year revenue growth and the company’s first GAAP operating profit as meaningful milestones. The launch of AI automation with One NZ marks broader international adoption and growing product relevance. He considers the consolidation phase as support building for the next bullish leg. "With growth and product momentum accelerating, I expect UiPath to reward patient investors as market sentiment shifts."

Parshwa Turakhiya, analyst, notes that bearish short-term sentiment is reinforced by indicators like MACD and RSI. He views the $10 mark as a tactical support level, where oversold signals may trigger brief rebounds despite negative momentum. The volatility band between $9.71 and $10.35 offers active traders defined risk-reward setups. "I see short-term opportunities for nimble traders, but conviction for sustained upside demands a break above $10.31."

Broad-based weakness as bearish momentum converges across signals

UiPath remains below the $11.03 20-day, $10.71 50-day, and $12.99 200-day moving averages, indicating weakened momentum across all time frames. The near-term trading setup is bearish, with resistance at $10.31 and support forming around $10. Momentum indicators such as MACD and ADX show sell or neutral signals, while RSI at 43.14 suggests ongoing selling pressure. CCI and Stochastic RSI confirm oversold conditions. BBP is slightly positive, implying a slim hold by buyers intraday. The Awesome Oscillator further confirms negative momentum, with the stock moving near its session low and intraday volatility at 3.72%.

Earlier, analysts noted that UiPath’s operational momentum and international expansion were beginning to challenge persistent bearish sentiment, though a clear directional shift had yet to materialize. The current technical breakdown and renewed downside risk reinforce that sellers remain in control, making a decisive move above $10.31 the key signal traders should watch for any shift in trend.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.